Status:
COMPLETED
Evaluation of the Long Term Efficacy of Endovascular Treatment of Type 2 Endoleaks
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Abdominal Aortic Aneurysm
Eligibility:
All Genders
18-99 years
Brief Summary
Endovascular treatment has become the first choice to repair abdominal aortic aneurym, but exposes patients to a risk of endoleaks. Although treatment of type 1 and 3 endoleaks has proven to prevent a...
Eligibility Criteria
Inclusion
- All patients treated for type II endoleaks by endovascular therapy
Exclusion
- None
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 26 2020
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT04409717
Start Date
January 1 2020
End Date
May 26 2020
Last Update
June 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiovascular and thoracic surgery unit, CHU Dijon
Dijon, France, 21079